Boardroom Alpha
Boardroom Alpha
ALKT · Current Report (Form 8-K) · Filed May 20, 2026

Alkami Technology Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 20, 2026
Period
May 19, 2026
Ticker
ALKT
Accession
0001529274-26-000043
Boardroom Alpha · Filing insights

All three Class II director nominees were elected; EY was ratified as auditor; and executive compensation was approved.

About Alkami Technology Inc
Market cap
$1.9B
1Y TSR
−41.1%
3Y TSR
+3.1%
Board grade
C
Sector
Technology
CEO
Alex Shootman
Last annual meeting: May 19, 2026 · View full Alkami Technology Inc profile →
alk-20260519


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 19, 2026

ALKAMI TECHNOLOGY, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware     001-40321     45-3060776
(State or Other Jurisdiction of Incorporation) (Commission File Number)     (IRS Employer Identification No.)

5601 Granite Parkway, Suite 120, Plano, TX 75024
(Address of Principal Executive Offices) (Zip Code)
(877) 725-5264
Registrant’s Telephone Number, Including Area Code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareALKT
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐











Item 5.07. Submission of Matters to a Vote of Security Holders.

Alkami Technology, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on May 19, 2026. On March 23, 2026, the record date for the Annual Meeting, 107,016,974 shares of the Company’s common stock were entitled to vote at the Annual Meeting, of which 76,909,758 shares, or 71.87%, were represented in person or by proxy at the Annual Meeting.

The following proposals were submitted to a vote of stockholders at the Annual Meeting, each of which is described in detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 7, 2026.

1.    The election of three nominees to serve as Class II directors to hold office until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.
ForWithheldBroker Non-Votes
Charles Kane70,325,5341,069,2375,514,987
Alex Shootman70,222,6491,172,1225,514,987
Brian R. Smith52,065,03419,329,7375,514,987

Based on the votes set forth above, all of the director nominees were duly elected.

2.    The ratification of the appointment of Ernst & Young LLP by the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
ForAgainstAbstainBroker Non-Votes
76,636,547172,329100,8820

Based on the votes set forth above, the appointment of Ernst & Young LLP by the Audit Committee as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.

3.    Advisory vote to approve the compensation of the Company’s named executive officers.
ForAgainstAbstainBroker Non-Votes
69,605,9421,702,58986,2405,514,987

Based on the votes set forth above, the stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alkami Technology, Inc.
Date:May 20, 2026By:/s/ Cassandra Hudson
Cassandra Hudson
Chief Financial Officer

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Alkami Technology Inc (ALKT)

Reference

Frequently asked questions

When did Alkami Technology Inc file this 8-K?
Alkami Technology Inc (ALKT) filed this Current Report (Form 8-K) with the SEC on May 20, 2026. The accession number assigned by EDGAR is 0001529274-26-000043.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All three Class II director nominees were elected; EY was ratified as auditor; and executive compensation was approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Alkami Technology Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Alkami Technology Inc has filed under CIK 1529274, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer